Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector

Samankaltaisia teoksia

• Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
  Julkaistu: (2014-01-01)
• Assessing immunogenicity barriers of the HIV-1 envelope trimer
  Tekijä: Liridona Maliqi, et al.
  Julkaistu: (2023-09-01)
• A modification to heptad repeat 1 of gp41 improves yield and/or quality of soluble pre-fusion HIV-1 envelope glycoprotein trimers
  Tekijä: Devidas N. Chaturbhuj, et al.
  Julkaistu: (2025-09-01)
• Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
  Tekijä: Catherine A Cosgrove, et al.
  Julkaistu: (2016-01-01)
• ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.
  Tekijä: Leigh H Fisher, et al.
  Julkaistu: (2025-01-01)